EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Incidence and predictive factors of hyperventilation syndrome in patients after COVID 19 pneumonia: a prospective cohort study

Hela Cherif iD, Salma Mokaddem iD, Soumaya Debiche iD, Slim Kalboussi, Ferdaous Yangui iD, Mohamed Ridha Charfi

F1000Research · 2024

DOI: 10.12688/f1000research.152196.1 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift F1000Research, 2024. Verfasst von Hela Cherif und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, Internal Security Forces Hospital, Tunis, Tunisia. Hauptthemen laut MEDLINE: COVID-19, Hyperventilation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigates the incidence and predictive factors of Hyperventilation Syndrome (HVS) in patients after COVID 19 pneumonia, addressing the clinical overlap between these conditions.

Methods

A one-month prospective study was conducted, tracking survivors of COVID-19 pneumonia. Patients were evaluated for ongoing clinical status, including HVS and post-traumatic syndrome disorder (PTSD), using clinical questionnaires, mMRC, Post-COVID-19 Functional Status (PCFS) Score, Nijmegen score, and PTSD Checklist for DSM-5 questionnaire.

Results

Our study included 222 patients (median age: 57 years, male predominance 62.6%). Somatic comorbidities, primarily metabolic disorders, were reported in 71.2% of cases. The majority had severe or critical infection forms (78.4%), and 91.9% experienced acute symptoms, with 86.5% having three or more symptom clusters. At one month follow-up, dyspnea (52.9%) and asthenia (21.7%) persisted. Functional limitations (PCFS Grade > 2) were observed in 19.6% of patients. The overall incidence of HVS was 158 per 1000 patients, and PTSD was 445 per 1000 patients. Multivariate logistic regression identified cognitive impairment (acute phase), persistent weight loss (post-COVID-19 phase), PCFS grade > 2, and PTSD as independent factors for developing HVS, with relative risks (RRs) of 3.47 (95%CI [1.48-8.31]; p = 0.004), 11.87 (95%CI [1.25-112.88]; p = 0.031), 3.24 (95%CI [1.34-7.86]; p = 0.009), and 5.98 (95%CI [2.27-15.77]; p < 0.001), respectively.

Conclusion

HVS is prevalent in the post-COVID-19 phase, affecting 15.6 % of survivors. Identified predictive factors suggest the convergence of psychosomatic pathophysiological mechanisms. Further research is crucial for a detailed understanding of these mechanisms in long COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HyperventilationHumansMaleFemaleMiddle AgedIncidenceProspective StudiesAgedAdultSARS-CoV-2Stress Disorders, Post-TraumaticRisk FactorsComorbiditySyndrome

Stichwörter der Autor:innen

Hyperventilation Syndrome; COVID-19 pneumonia; Post-Traumatic Stress Disorder;…

Autor:innen und Institutionen

  • Pulmonology Department, Internal Security Forces Hospital, Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunis, Tunisia.
  • Research Laboratory on Health and Environment for security Foces LR21INT01, Tunis, Tunisia.

ORCID-Profile: Hela Cherif, Salma Mokaddem, Soumaya Debiche, Ferdaous Yangui

Zitieren

APA

Cherif, H., Mokaddem, S., Debiche, S., Kalboussi, S., Yangui, F., & Charfi, M. R. (2024). Incidence and predictive factors of hyperventilation syndrome in patients after COVID 19 pneumonia: a prospective cohort study. F1000Research. https://doi.org/10.12688/f1000research.152196.1

Vancouver

Cherif H, Mokaddem S, Debiche S, Kalboussi S, Yangui F, Charfi MR. Incidence and predictive factors of hyperventilation syndrome in patients after COVID 19 pneumonia: a prospective cohort study. F1000Research. 2024. doi:10.12688/f1000research.152196.1

BibTeX
@article{Cherif2024,
  author = {Cherif, Hela and Mokaddem, Salma and Debiche, Soumaya and Kalboussi, Slim and Yangui, Ferdaous and Charfi, Mohamed Ridha},
  title = {Incidence and predictive factors of hyperventilation syndrome in patients after COVID 19 pneumonia: a prospective cohort study},
  journal = {F1000Research},
  year = {2024},
  doi = {10.12688/f1000research.152196.1}
}
Kostenlos starten →